Treatment of metastatic alveolar soft part sarcoma with axitinib and pembrolizumab in an 80-year-old patient with a history of autoimmune disorders

aDepartment of Internal Medicine III, Klinikum Grosshadern, Ludwig-Maximilians-University of Munich

bDepartment of Radiology, University Hospital, LMU Munich

cInstitute of Pathology, Ludwig-Maximilians-University of Munich, Munich

dComprehensive Cancer Center Munich, University Hospital, Ludwig-Maximilians-University of Munich, Munich

eGerman Cancer Consortium (DKTK), Partner Site Munich and German Cancer Research Centre (DKFZ), Heidelberg, Germany

Received 25 June 2022 Revised form accepted 27 June 2022

Correspondence to: Lars Lindner, MD, Department of Internal Medicine III and Comprehensive Cancer Center, Klinikum Grosshadern, Ludwig-Maximilians-University of Munich, Marchioninistr. 15, D-81377 Munich, Germany, Tel: +0049 89 4400 74768; e-mail: [email protected]

留言 (0)

沒有登入
gif